Acute Respiratory Distress Syndrome: Bench‐to‐Bedside Approaches to Improve Drug Development

Despite 50 years of extensive research, no definite drug is currently available to treat acute respiratory distress syndrome (ARDS), and the supportive therapies remain the mainstay of treatment. To improve drug development for ARDS, researchers need to deeply analyze the “omics” approaches, reevalu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Pharmacol Ther
Main Authors: Hussain, Musaddique, Xu, Chengyun, Ahmad, Mashaal, Majeed, Abdul, Lu, Meiping, Wu, Xiling, Tang, Lanfang, Wu, Ximei
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2018
Assuntos:
Reviews
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7162218/
https://ncbi.nlm.nih.gov/pubmed/29484641
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpt.1034
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados